Newland Pharmaceutical Co Ltd Class A 301277
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥13.06
- Day Range
- ¥13.13–14.10
- 52-Week Range
- ¥9.30–18.38
- Bid/Ask
- ¥13.81 / ¥13.82
- Market Cap
- ¥3.87 Bil
- Volume/Avg
- 7.9 Mil / 3.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 23.95
- Price/Sales
- 5.40
- Dividend Yield (Trailing)
- 2.89%
- Dividend Yield (Forward)
- 2.89%
- Total Yield
- 2.89%
Company Profile
Newland Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chiral pharmaceutical intermediates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,010
- Website
- http://www.newlandpharma.com
Comparables
Valuation
|
Metric
|
301277
|
832735
|
830946
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.95 | 12.53 | 23.52 |
Price/Book Value | 2.61 | 1.89 | 2.64 |
Price/Sales | 5.40 | 2.40 | 5.53 |
Price/Cash Flow | 19.02 | 10.68 | 16.43 |
Price/Earnings
301277
832735
830946
Financial Strength
|
Metric
|
301277
|
832735
|
830946
|
|---|---|---|---|
Quick Ratio | 5.50 | 3.55 | 7.55 |
Current Ratio | 5.69 | 3.87 | 9.58 |
Interest Coverage | — | 201.60 | 146.70 |
Quick Ratio
301277
832735
830946
Profitability
|
Metric
|
301277
|
832735
|
830946
|
|---|---|---|---|
Return on Assets (Normalized) | 9.99% | 13.08% | 10.16% |
Return on Equity (Normalized) | 11.36% | 15.89% | 11.79% |
Return on Invested Capital (Normalized) | 11.10% | 15.06% | 9.43% |
Return on Assets
301277
832735
830946
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Mbgjjcjclq | Tdxfp | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Ffnxxbbwy | Wbfkjm | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Snmbmwy | Vdr | $48.4 Bil | |||
| Viatris Inc
VTRS
| Mxtqdsjl | Vrln | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Dnvgmcsg | Qnlhy | $13.5 Bil | |||
| Catalent Inc
CTLT
| Sltcywwb | Czjlvt | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Gwjqsbnb | Fxtgrxp | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Lmdjkwts | Bbwd | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Srzfyjjtj | Fqh | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Bfxhznxtv | Rznd | $2.3 Bil |
United States